Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from BML ( (JP:4694) ) is now available.
BML, Inc. has announced a strategic absorption-type merger with its wholly owned subsidiary, BML Life Science Holdings, Inc., effective September 1, 2025. This merger aims to streamline operations and improve management efficiency within the group, with BML, Inc. remaining as the surviving entity. The merger will not involve any issuance of new shares or changes to the company’s structure, ensuring a smooth transition and continued focus on core business activities.
More about BML
BML, Inc. operates in the contract clinical testing industry and provides related services. It is a well-established company with a significant presence in the market, focusing on enhancing management efficiency through strategic mergers.
Average Trading Volume: 86,485
Technical Sentiment Signal: Buy
Current Market Cap: Yen126B
See more data about 4694 stock on TipRanks’ Stock Analysis page.